ALL KEYWORDSEyelid MelanomaRelated SpecialistsSean ChristensenMD, PhDKathleen Cook SuozziMDRelated Fact SheetsMelanomaRelated Clinical TrialsR3767-ONC-22122: A Phase 3 Study of Fixed Dose Combinations of Fianlimab and Cemiplimab Versus Relatilimab and Nivolumab in Participants with Unresectable or Metastatic MelanomaSkin Cancers & MelanomaRelated DepartmentsShowing 3 of 10Dermatologic SurgeryCutaneous Oncology ProgramDermatologyMore Related Departments
